Endocannabinoid signaling transcends pain

Archives of Medical Science

Volumn 5, Issue 4, 2009, Pages 602-612

  Stefano, George B ^a   Kream, Richard M ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

9 tetrahydrocannabinol; Anandamide; CB receptors; Immune cells; Morphine; Nitric oxide

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; ANANDAMIDE; ANTIHYPERTENSIVE AGENT; ARACHIDONIC ACID; CANNABINOID; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CATECHOLAMINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; COCAINE; DRONABINOL; ENDOCANNABINOID; ENZYME INHIBITOR; ESTROGEN; ICOSANOID; LIGAND; METHYL ARACHIDONYL FLUOROPHOSPHONATE; MORPHINE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NICOTINE; NITRIC OXIDE; OPIATE; PALMIDROL; POTASSIUM CHANNEL; RIMONABANT; TESTOSTERONE; UNCLASSIFIED DRUG;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; BINDING AFFINITY; BLOOD PRESSURE REGULATION; BRADYCARDIA; CATECHOLAMINE RELEASE; CELL COMMUNICATION; CONFERENCE PAPER; DRUG BINDING; DRUG BINDING SITE; DRUG INHIBITION; DRUG MECHANISM; EVOLUTION; HUMAN; IMMUNOMODULATION; INHIBITION KINETICS; INVERTEBRATE; LYMPHOCYTE; MAMMAL; MOLECULE; MONOAMINE NERVE CELL; NERVE CELL CULTURE; NERVOUS TISSUE; NONHUMAN; PAIN; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; STEREOCHEMISTRY; VASCULAR TISSUE; VERTEBRATE;

EID: 75349106915     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (114)

1. Herer J. The Emperor Wears No Clothes: The Authoritative Historical Record of Cannabis and the Conspiracy Against Marijuana. 11th ed. New York, NY: AH HA Publishing Co. 1998.
2. Stefano GB. Conformational matching: a possible evolutionary force in the evolvement of signal systems. In: Stefano GB (eds). CRC Handbook of comparative opioid and related neuropeptide mechanisms. Boca Raton: CRC Press 1986; 271-7.
3. Stefano GB. Conformational matching: a possible evolutionary force in the evolvement of signal systems. In: Stefano GB (eds). CRC Handbook of comparative opioid and related neuropeptides mechanisms. Boca Raton: CRC Press Inc 1986; 271-7.
4. Acosta-Urquidi J, Chase R. The effects of delta9-tetrahydrocannabinol on action potentials in the mollusc Aplysia. Can J Physiol Pharmacol 1975; 53: 793-8.
5. McClean DK, Zimmerman AM. Action of delta 9-tetrahy drocannabinol on cell division and macromolecular synthesis in division-synchronized protozoa. Pharmacology 1976; 14: 307-21.
6. Zimmerman S, Zimmerman AM, Laurence H. Effect of delta 9-tetrahydrocannabinol on cyclic nucleotides in synchronously dividing Tetrahymena. Can J Bioch 1981; 59: 489-93.
7. Baczynsky WO, Zimmerman AM. Effects of delta9-tetrahydrocannabinol, cannabinol, and cannabidiol on the immune system in miceI. In vivo investigation of the primary and secondary immune response. Pharmacology 1983; 26: 1-11.
8. Schuel H, Goldstein E, Mechoulam R, Zimmerman AM, Zimmerman S. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proc Natl Acad Sci USA 1994; 91: 7678-82.
9. Bisogno T, Ventriglia M, Milone A, Mosca M, Cimino G, Di Marzo V. Occurrence and metabolism of anandamide and related acyl-ethanolamides in ovaries of the sea urchin Paracentrotus lividus. Biochim Biophys Acta 1997; 1345: 338-48.
10. Berdyshev EV. Inhibition of sea urchin fertilization by fatty acid ethanolamides and cannabinoids. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1999; 122: 327-30.
11. Stefano GB, Liu Y, Goligorsky MS. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem 1996; 271: 19238-42.
12. Stefano GB, Hartman A, Bilfinger TV, et al. Presence of the mu3 opiate receptor in endothelial cells: Coupling to nitric oxide production and vasodilation. J Biol Chem 1995; 270: 30290-3.
13. Liu Y, Shenouda D, Bilfinger TV, Stefano ML, Magazine HI, Stefano GB. Morphine stimulates nitric oxide release from invertebrate microglia. Brain Res 1996; 722: 125-31.
14. Magazine HI, Liu Y, Bilfinger TV, Fricchione GL, Stefano GB. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J Immunol 1996; 156: 4845-50.
15. Stefano GB, Bilfinger TV, Rialas CM, Deutsch DG. 2-Arachidonyl-glycerol stimulates nitric oxide from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. Pharmacol Res 2000; 42: 317-22.
16. Sepe N, De Petrocellis L, Montanaro F, Cimino G, Di Marzo V. Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs. Possible implications for mollusc physiology and sea food industry. Biochim Biophys Acta 1998; 1389: 101-11.
17. Stefano GB, Salzet B, Rialas CM, et al. Morphine- and anandamide- stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res 1997; 763: 63-8.
18. Stefano GB, Hall B, Makman MH, Dvorkin B. Opioid inhibition of dopamine release from nervous tissue of Mytilus edulis and Octopus bimaculatus. Science 1981; 213: 928-30.
19. Stefano GB, Salzet B, Salzet M. Identification and characterization of the leech CNS cannabinoid receptor: coupling to nitric oxide release. Brain Res 1997; 753: 219-24.
20. Stefano GB, Rialas CM, Deutsch DG, Salzet M. Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues. Brain Res 1998; 793: 341-5.
21. De Petrocellis L, Melck D, Bisogno T, Milone A, Di MV. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience 1999; 92: 377-87.
22. Benowitz NL, Jones RT. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther 1974; 18: 287-97.
23. Rosenkrantz H. Cannabis, marijuana and cannabinoid toxicological manifestations in man and animals. In: O'Brien K, Kalant H (eds). Cannabis and health hazards. Toronto: Addiction Research Foundation 1983; 91-175.
24. Varga K, Lake K, Martin BR, Kunos G. Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 1995; 278: 279-83.
25. Siqueira SW, Lapa AJ, Ribeiro DV. The triple effect induced by delta 9-tetrahydrocannabinol on the rat blood pressure. Eur J Pharmacol 1979; 58: 351-7.
26. Stein EA, Fuller SA, Edgemond WS, Campbell WB. Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. Br J Pharmacol 1996; 119: 107-14.
27. Lake KD, Compton DR, Varga K, Martin BR, Kunos G. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors. J Pharmacol Exp Therap 1997; 281: 1030-7.
28. Lake KD, Martin BR, Kunos G, Varga K. Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 1997; 29: 1204-10.
29. Deutsch DG, Goligorsky MS, Schmid PC, et al. Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Investig 1997; 100: 1538-46.
30. Varga K, Lake KD, Huangfu D, Guyenet PG, Kunos G. Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 1996; 28: 682-6.
31. Ledent C, Valverde O, Cossu G, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 1999; 283: 401-4.
32. Jarai Z, Wagner JA, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A 1999; 96: 14136-41.
33. Sugiura T, Kodaka T, Nakane S, Kishimoto S, Kondo S, Waku K. Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem Biophys Res Com 1998; 243: 838-43.
34. Liu J, Gao B, Mirshahi F, et al. Functional CB1 cannabinoid receptors in vascular endothelial cells. Biochem J 2000; in press.
35. Van der Kloot W. Anandamide, a naturally occurring agonist of the cannabinoid receptor, blocks adenylate cyclase at the frog neuromuscular junction. Brain Res 1994; 649: 181-4.
36. Mechoulam R, Ben-Shabat S, Hanus L, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995; 50: 83-90.
37. Egi Y, Matsumura Y, Murata S, et al. The effects of NG-nitro-L-arginine, a nitric oxide synthase inhibitor, on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs. J Pharmacol Exp Ther 1994; 269: 529-35.
38. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 1994; 23: 971-5.
39. Bilfinger TV, Salzet M, Fimiani C, Deutsch DG, Stefano GB. Pharmacological evidence for anandamide amidase in human cardiac and vascular tissues. Int J Cardiol 1998; 64: S15-22.
40. Stefano GB, Salzet M, Magazine HI, Bilfinger TV. Antagonist of LPS and IFN-g induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 1998; 31: 813-20.
41. Randall MD, Kendall DA. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol 1997; 335: 205-9.
42. Sawada M, Ichinose M, Stefano GB. Inhibition of the met-enkephalin induced K+ current in B cluster neurons of Aplysia by nitric oxide donor. Brain Res 1996; 740: 124-30.
43. Wagner JA, Varga K, Ellis EF, Rzigalinski BA, Martin BR, Kunos G. Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature 1997; 390: 518-21.
44. Bilfinger TV, Hartman AR, Liu Y, Magazine HI, Stefano GB. Cryopreserved veins in myocardial revascularization: Possible mechanism for their increased failure. Ann Thoracic Surgery 1997; 63: 1063-9.
45. Stefano GB. Autoimmunovascular regulation: Morphine and anandamide stimulated nitric oxide release. J Neuroimmunol 1998; 83: 70-6.
46. Fimiani C, Magazine HI, Welters I, et al. Antagonism of LPS and IFN-g induced iNOS expression in human atrial endothelia by morphine, anandamide and estrogen. Acta Pharmacol Sinica 2000; 21: P405-9.
47. Graham JP. The cardiovascular actions of cannabinoids. In: Mechoulam R (eds). Cannabinoids as therapeutic agents. Boca Raton, FL: CRC Press Inc 1986.
48. Burnette-Curley D, Cabral GA. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol. Proc Soc Exp Biol Med 1995; 210: 64-76.
49. McCoy KL, Gainey D, Cabral GA. Delta-9-tetrahydro cannabinol modulates antigen processing by macrophages. J Pharmacol Exp Ther 1995; 273: 1216-23.
50. Zheng ZM, Spector S, Friedman H. Inhibition by delta-9- tetrahydrocannabinol of tumor necrosis factor alpha production by mouse and human macrophages. Int J Immunopharmacol 1992; 14: 1445-52.
51. Cabral GA, Fischer-Stenger K. Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol. Life Sci 1994; 54: 1831-44.
52. Shivers SC, Newton C, Friedman H, Klein T. delta-9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell lines. Life Sci 1994; 54: 1281-9.
53. Tang JL, Lancz G, Spector S, Bullock H. Marijuana and immunity: tetrahydrocannabinol-mediated inhibition of growth and phagocytic acitivity of the murine macrophage cell line, P388D1. Int J Immunopharmacol 1992; 14: 253-62.
54. Friedman M, Cepero ML, Klein T, Friedman H. Suppressive effect of delta-9-tetrahydrocannabinol in vitro on phagocytosis by murine macrophages. Proc Soc Exp Biol Med 1986; 182: 225-8.
55. Lopez-Cepero M, Friedman M, Klein T, Friedman H. Tetrahydrocannabinol- induced suppression of macrophage spreading and phagocytic activity in vitro. J Leukocyte Biol 1986; 39: 679-86.
56. Specter S, Lancz G, Westrich G, Friedman H. Combined immunosuppressive activities of delta9- tetrahydro cannabinol and murine retrovirus. In: Friedman H, Specter S, Klein TW (eds). Advances in experimental medicine and biology. New York: Plenum Press 1991; 135-41.
57. Specter S, Lancz G, Westrich G, Friedman H. Delta9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int J Immunopharmacol 1991; 13: 411-7.
58. Specter S, Lancz G, Goodfellow D. Suppression of human macrophage function in vitro by delta 9-tetrahydrocannabinol. J Leukocyte Biology 1991; 50: 423-6.
59. Specter S, Klein TW, Newton C, Mondragon M, Widen R, Friedman H. Marijuana effects on immunity: suppression of human natural killer cell activity by delta9-tetrahydrocannabinol. Int J Immunopharmacol 1986; 8: 741-5.
60. Stefano GB, Hartman A, Bilfinger TV, et al. Morphine stimulates nitric oxide production in endothelial cells by way of the m3 opiate receptor. Proc Natl Acad Sci USA 1995.
61. Stefano GB, Hartman A, Bilfinger TV, et al. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 1995; 270: 30290-3.
62. Stefano GB, Scharrer B, Smith EM, et al. Opioid and opiate immunoregulatory processes. Crit Rev Immunol 1996; 16: 109-44.
63. Stefano GB, Liu Y. Opiate antagonism of opioid actions on immunocyte activation and nitric oxide release. Anim Biol 1996; 1: 11-6.
64. Fricchione G, Zhu W, Cadet P, et al. Identification of endogenous morphine and a mu3-like opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy. Med Sci Monit 2008; 14: CS45-9.
65. Mantione KJ, Cadet P, Zhu W, et al. Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: autocrine/paracrine feedback inhibition. Addict Biol 2008; 13: 118-23.
66. Stefano GB, Stefano JM, Esch T. Anticipatory stress response: a significant commonality in stress, relaxation, pleasure and love responses. Med Sci Monit 2008; 14: RA17-21.
67. Stefano GB, Cadet P, Kream RM, Zhu W. The presence of endogenous morphine signaling in animals. Neurochem Res 2008; 33: 1933-9.
68. Stefano GB, Kream RM, Mantione KJ, et al. Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology. Semin Cancer Biol 2008; 18: 199-210.
69. Stefano GB, Kream R. Endogenous opiates, opioids, and immune function: evolutionary brokerage of defensive behaviors. Semin Cancer Biol 2008; 18: 190-8.
70. Zhu W, Esch T, Kream RM, Stefano GB. Converging cellular processes for substances of abuse: endogenous morphine. Neuro Endocrinol Lett 2008; 29: 63-6.
71. Atmanene C, Laux A, Glattard E, et al. Characterization of human and bovine phosphatidylethanolamine-binding protein (PEBP/RKIP) interactions with morphine and morphine-glucuronides determined by noncovalent mass spectrometry. Med Sci Monit 2009; 15: BR178-87.
72. Stefano GB, Esch T, Kream RM. Xenobiotic perturbation of endogenous morphine signaling: paradoxical opiate hyperalgesia. Med Sci Monit 2009; 15: RA107-10.
73. Stefano GB, Kream RM, Esch T. Revisiting tolerance from the endogenous morphine perspective. Med Sci Monit 2009; 15: RA189-98.
74. Stefano GB, Kream RM. Dopamine, morphine, and nitric oxide: An evolutionary signaling triad. CNS Neurosci Therap 2009; in press.
75. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for can nabinoids. Nature 1993; 365: 61-5.
76. Devane MA, Spain JW, Coscia CJ, Howlett AC. An assessment of the role of opioid receptors in the response to cannabimimetic drugs. J Neurochem 1986; 46: 1929-35.
77. Stefano GB, Scharrer B, Smith EM, et al. Opioid and opiate immunoregulatory processes. Crit Rev Immunol 1996; 16: 109-44.
78. Stefano GB, Scharrer B, Fricchione GL. Endogenous morphine and the physiological significance of tolerance in amplification brain phenomena. In review, 1996.
79. Stefano GB, Salzet M. Characterization and coupling of the leech CNS cannabinoid receptor to nitric oxide release. J Biol Chem 1996.
80. O'Brien CP. Drug addiction and drug abuse. In: Hardman JG and Limbird LE (eds). The pharmacological basis of therapeutics. New York: McGraw Hill 1996; 557-79.
81. Stefano GB, Salzet M, Bilfinger TV. Long-term exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: Uncoupling of Nitric Oxide. J Cardiovasc Pharmacol 1998; 31: 862-8.
82. Stefano GB, Salzet M, Rialas C, Mattocks DW, Fimiani C, Bilfinger TV. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: Endothelial implications. Int J Cardiol 1998; 64: S3-13.
83. Stefano GB, Salzet M, Magazine HI, Bilfinger TV. Anandamide or morphine stimulate saphenous vein endothelium cNOS nitric oxide release which downregulates LPS and IFN-g iNOS by inhibiting adenylate cyclase. J Cardiol Pharmacol 1998; 31: 813-20.
84. Magazine HI, Chang J, Goumon Y, Stefano GB. Rebound from nitric oxide inhibition triggers enhanced monocyte activation and chemotaxis. J Immunol 2000; 165: 102-7.
85. Prevot V, Croix D, Rialas CM, et al. Estradiol coupling to endothelial nitric oxide production stimulates GnRH release from rat median eminence. Endocrinol 1999; 140: 652-9.
86. Prevot V, Croix D, Rialas CM, et al. Estradiol coupling to endothelial nitric oxide stimulates gonadotropin- releasing hormone release from rat median eminence via a membrane receptor. Endocrinology 1999; 140: 652-9.
87. Stefano GB, Prevot V, Beauvillain JC, et al. Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: Evidence for an estrogen surface receptor. J Immunol 1999; 163: 3758-63.
88. Roy JR, Chakraborty S, Chakraborty TR. Estrogen-like endocrine disrupting chemicals affecting puberty in humans - a review. Med Sci Monit 2009; 15: RA137-45.
89. Singh MN, Martin-Hirsch PL, Martin FL. The multiple applications of tamoxifen: an example pointing to SERM modulation being the aspirin of the 21st century. Med Sci Monit 2008; 14: RA144-8.
90. Mantione KJ. Estrogen's actions transcend a sole reproductory function in cell signaling. Med Sci Monit 2008; 14: SC1-3.
91. Pflueger A, Abramowitz D, Calvin AD. Role of oxidative stress in contrast-induced acute kidney injury in diabetes mellitus. Med Sci Monit 2009; 15: RA125-36.
92. De GC, Bianchi M, Pascale V, et al. Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. Med Sci Monit 2009; 15: RA91-101.
93. Tanii H, Higashi T, Nishimura F, Higuchi Y, Saijoh K. Effects of cruciferous allyl nitrile on phase 2 antioxidant and detoxification enzymes. Med Sci Monit 2008; 14: BR189-92.
94. Benz D, Cadet P, Mantione K, Zhu W, Stefano GB. Tonal nitric oxide and health: A free radical and a scavenger of free radicals. Med Sci Monit 2002; 8: 1-4.
95. Benz D, Cadet P, Mantione K, Zhu W, Stefano GB. Tonal nitric oxide and health: Anti-bacterial and -viral actions and implications for HIV. Med Sci Monit 2002; 8: RA27-31.
96. Gu Y, Yun L, Tian Y, Hu Z. Association between COMT gene and Chinese male schizophrenic patients with violent behavior. Med Sci Monit, 2009; 15: CR484-9.
97. Yokoyama H, Hirose H, Saito I. Two types of unsafe drinker judged to have metabolic syndrome: typical metabolic syndrome or alcohol-related syndrome? Med Sci Monit 2009; 15: H57-64.
98. Yokusoglu M, Sag C, Cincik M, et al. Perindopril, atenolol, and amlodipine prevent aortic ultrastructural changes in rats exposed to ethanol. Med Sci Monit 2008; 14: BR96-102.
99. Naha N, Lee HY, Naser MI, Park TJ, Kim SH, Kim MO. Ethanol inhibited apoptosis-related RNA binding protein, Napor-3 gene expression in the prenatal rat brain. Med Sci Monit 2009; 15: BR6-12.
100. Zhu W. CYP2D6: a key enzyme in morphine synthesis in animals. Med Sci Monit 2008; 14: SC15-18.
101. Castardeli E, Duarte DR, Minicucci MF, et al. Exposure time and ventricular remodeling induced by tobacco smoke exposure in rats. Med Sci Monit 2008; 14: BR62-6.
102. Kopeckova M, Paclt I, Petrasek J, Pacltova D, Malikova M, Zagatova V. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age. Neuro Endocrinol Lett 2008; 29: 246-51.
103. Nikisch G. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function. Neuro Endocrinol Lett 2009; 30: 11-6.
104. Gavrilovic L, Spasojevic N, Tanic N, Dronjak S. Chronic isolation of adult rats decreases gene expression of catecholamine biosynthetic enzymes in adrenal medulla. Neuro Endocrinol Lett 2008; 29: 1015-20.
105. Stefano GB, Scharrer B. Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol 1994; 4: 57-68.
106. Stefano GB, Goumon Y, Bilfinger TV, Welters I, Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor. Progress Neurobiology 2000; 60: 513-30.
107. Cadet P, Mantione KJ, Stefano GB. Molecular identification and functional expression of mu3, a novel alternatively spliced variant of the human mu opiate receptor gene. J Immunol 2003; 170: 5118-23.
108. Cadet P, Mantione KJ, Zhu W, Kream RM, Sheehan M, Stefano GB. A functionally coupled mu3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells. J Immunol 2007; 179: 5839-44.
109. Kream RM, Sheehan M, Cadet P, et al. Persistence of evolutionary memory: Primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling. Med Sci Monit 2007; 13: SC5-6.
110. Stefano GB, Bianchi E, Guarna M, et al. Nicotine, alcohol and cocaine coupling to reward processes via endogenous morphine signaling: The dopaminemorphine hypothesis. Med Sci Monit 2007; 13: RA91-102.
111. Stefano GB, Kream RM. Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (Review). Int J Mol Med 2007; 20: 837-41.
112. Zhu W, Mantione KJ, Kream RM, Cadet P, Stefano GB. Cholinergic regulation of morphine release from human white blood cells: evidence for a novel nicotinic receptor via pharmacological and microarray analysis. Int J Immunopathol Pharmacol 2007; 20: 229-37.
113. Kream RM, Stefano GB. Homeopathic ethanol. Med Sci Monit 2008; 14: SC11-3.
114. Mantione KJ, Kream RM, Stefano GB. Variations in critical morphine biosynthesis genes and their potential to influence human health. Neuroendocrinol Lett 2009; in press.